[Customization of hormonal contraception].

Area of Science:

• Reproductive Health
• Pharmacology
• Women's Health

Background:

• Recent advancements in oral contraceptives aim to enhance safety and efficacy for women.
• Modifications focus on both estrogenic and progestin components of contraceptive formulations.

Purpose of the Study:

• To review the evolution of oral contraceptive compounds and administration methods.
• To highlight improvements in safety profiles and management of side effects.

Main Methods:

• Review of recent developments in oral contraceptive formulations.
• Analysis of changes in estrogenic and progestin components.
• Examination of altered administration regimens and routes.

Main Results:

• Reduced ethinyl estradiol doses and use of natural estradiol improve safety.
• New progestins offer non-androgenic or anti-androgenic properties, benefiting conditions like hyperandrogenism.
• Drospirenone's antimineralcorticoid action reduces fluid retention; dienogest and nomegestrole acetate are effective for abnormal uterine bleeding.
• Modified regimens and alternative administration routes (transdermal, transvaginal, etc.) decrease gastrointestinal interference and improve adherence.

Conclusions:

• Modern oral contraceptives provide enhanced safety and efficacy through optimized hormonal components and administration strategies.
• These innovations offer better management of side effects and improved patient outcomes in reproductive health.